Storia in 20 fonti

Weight-loss drug maker sues rival over which GLP-1 sheds the most pounds

Novo Nordisk claims Eli Lilly compared peak doses of Zepbound against outdated, lower doses of Wegovy to advertise a 50-pound weight loss versus 33 pounds

Raccontata da

economictimes.indiatimes.com

wiwo.de+8 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

independent.co.ukStai leggendo3 g fa

Weight-loss drug maker sues rival over which GLP-1 sheds the most pounds

Novo Nordisk claims Eli Lilly compared peak doses of Zepbound against outdated, lower doses of Wegovy to advertise a 50-pound weight loss versus 33 pounds

originale

Timeline cronologica

martedì 21 luglio 2026·biopharmadive.com
Novo sues Lilly, alleging ‘misleading’ advertising of obesity drugs
The lawsuit follows a cease-and-desist request and argues Lilly is using “deceptive” ads to claim its GLP-1 products are broadly superior to Novo’s medicines. Lilly countered that…
martedì 21 luglio 2026·forbes.com
Ozempic Maker Novo Nordisk Sues Eli Lilly For Deceptive Advertising
The lawsuit, filed in federal court Tuesday, accuses Eli Lilly of using outdated data in advertising campaigns.

Weight-loss drug maker sues rival over which GLP-1 sheds the most pounds

Confronto fonti

Weight-loss drug maker sues rival over which GLP-1 sheds the most pounds

Timeline cronologica

Novo sues Lilly, alleging ‘misleading’ advertising of obesity drugs

Ozempic Maker Novo Nordisk Sues Eli Lilly For Deceptive Advertising

Wegovy maker sues rival Eli Lilly over 'deliberately false' GLP-1 ads

Novo accuses rival Eli Lilly of "deceptive" weight-loss drug ads

GLP-1 Fight: Novo Sues Eli Lilly Over Nationwide "Deceptive Advertising" Campaign

Novo Nordisk sues Eli Lilly over ‘deliberately false’ weight-loss drug ads

Novo sues Lilly over 'deceptive' ads comparing GLP-1 drug doses

Novo Nordisk sues Eli Lilly over GLP-1 drug ads it calls ‘deceptive’

Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising

Novo Nordisk says it is suing Eli Lilly, accusing it of false advertising

Wegovy maker sues rival Eli Lilly over 'deliberately false' GLP-1 ads

Novo Nordisk sues Eli Lilly, accusing it of false advertising of weight-loss drug

GLP-1 Fight: Novo Sues Eli Lilly Over Nationwide "Deceptive Advertising" Campaign

Pharma heavyweights clash over anti-obesity drug ads

Novo Nordisk intente un procès à Eli Lilly pour publicité mensongère sur ses traitements anti-obésité

Novo Nordisk files lawsuit accusing rival Eli Lilly of running ‘false and misleading’ GLP-1 ads

Pharmaindustrie: Novo Nordisk verklagt US-Rivalen Eli Lilly

Novo Nordisk porta Eli Lilly in tribunale: pubblicità ingannevole sui farmaci anti-obesità | MilanoFinanza News

Novo Nordisk, fabricante de Ozempic y Wegovy, demanda a Eli Lilly; acusa publicidad engañosa sobre medicamentos contra obesidad y diabetes

Ozempic maker sues US rival over ad campaign

Novo Nordisk suing Eli Lilly over GLP-1 ‘outdated’ advertisements - UPI.com

Novo Nordisk demanda a Eli Lilly por “publicidad engañosa” de Zepbound frente a Ozempic y Wegovy

Novo Nordisk: Klage gegen Eli Lilly wegen unlauteren Wettbewerbs in den USA

Novo Nordisk Sues Eli Lilly Over Alleged Deceptive Weight Loss Drug Advertising - Novo Nordisk (NYSE:NVO)

Novo Nordisk sues Eli Lilly over "maliciously and deceptively false" GLP-1 ads